Junfen Fan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Circular RNAs in diseases 12
- RNA modifications and cancer 5
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 9
- Co-authors
- Hongling Li (10 shared papers)Robert Chunhua Zhao (10 shared papers)Huahao Fan (9 shared papers)Zehan Pang (4 shared papers)Qin Han (4 shared papers)Maochen Li (5 shared papers)Lili Tian (4 shared papers)Xisheng Weng (6 shared papers)
- Journals
- CNS Neuroscience & Therapeutics (7 papers)Aging and Disease (3 papers)Frontiers in Pharmacology (3 papers)Cell Death and Disease (3 papers)Journal of Neuroinflammation (2 papers)
- Partner nations
- ChinaUnited StatesLiechtenstein
In The Last Decade
Junfen Fan
61 papers receiving 1.8k citations
Junfen Fan's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 541
- Infectious Diseases 321
- Genetics 135
- Neurology 99
- Molecular Biology 754
Countries citing papers authored by Junfen Fan
This map shows the geographic impact of Junfen Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfen Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfen Fan more than expected).
Fields of papers citing papers by Junfen Fan
This network shows the impact of papers produced by Junfen Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfen Fan. The network helps show where Junfen Fan may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfen Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 vaccine development: milestones, lessons and prospects Hit paper breakdown → | 2022 | 275 |
| 2 | 2014 | 151 | |
| 3 | 2012 | 136 | |
| 4 | 2015 | 125 | |
| 5 | 2022 | 103 | |
| 6 | 2019 | 96 | |
| 7 | 2018 | 76 | |
| 8 | 2020 | 65 | |
| 9 | 2018 | 53 | |
| 10 | 2016 | 52 | |
| 11 | 2014 | 44 | |
| 12 | 2021 | 42 | |
| 13 | 2018 | 37 | |
| 14 | 2019 | 35 | |
| 15 | 2021 | 33 | |
| 16 | 2022 | 31 | |
| 17 | 2020 | 28 | |
| 18 | 2017 | 28 | |
| 19 | 2019 | 25 | |
| 20 | 2020 | 25 |
About Junfen Fan
Junfen Fan is a scholar working on Molecular Biology, Cancer Research, Neurology, Epidemiology and Immunology, having authored 70 papers that have together received 1.8k indexed citations. Recurring topics across this work include Circular RNAs in diseases (12 papers), MicroRNA in disease regulation (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Cancer-related molecular mechanisms research (9 papers), Acute Ischemic Stroke Management (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), RNA modifications and cancer (5 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Cancer Research (541 citations), Infectious Diseases (321 citations), Genetics (135 citations), Neurology (99 citations) and Molecular Biology (754 citations). Junfen Fan has collaborated with scholars based in China, United States and Liechtenstein. Frequent co-authors include Hongling Li, Robert Chunhua Zhao, Huahao Fan, Zehan Pang, Qin Han, Maochen Li, Lili Tian, Xisheng Weng, Yigang Tong and Lihua Song. Their work appears in journals such as CNS Neuroscience & Therapeutics, Aging and Disease, Frontiers in Pharmacology, Cell Death and Disease and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.